9.19MMarket Cap-0.32P/E (TTM)
1.4200High1.3800Low26.13KVolume1.4200Open1.4200Pre Close36.63KTurnover0.41%Turnover RatioLossP/E (Static)6.51MShares10.400052wk High-2.11P/B9.06MFloat Cap1.200052wk Low--Dividend TTM6.43MShs Float203.8900Historical High--Div YieldTTM2.82%Amplitude1.2000Historical Low1.4010Avg Price1Lot Size
Evogene Stock Forum
Revolutionary Discovery: New Weapon Against €1.2B Wheat Disease Threat Unveiled
Evogene Ltd: Unit Receives Notice of Termination of Licensing Agreement With Corteva for Bio Fungicide Lead Candidates
Lavie Bio Advances its Bio-Fungicide LAV321, Targeting Downy Mildew, to Pre-Commercial Stage Following Successful 2024 Field Trial Results
LAV321demonstrated strong results in its third consecutive year of field trials in Europe
REHOVOT, Israel, Nov. 19, 2024 /PRNewswire/ -- Lavie Bio Ltd., a leading ag-biologicals company and subsidiary of Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), today announced significant progress in the development of its LAV321 bio-fungicide, targeti...
Evogene Announces Collaboration With Google Cloud to Pioneer Generative AI Foundation Model for Novel Small Molecule Design
Watershed AC, Evogene and Ben-Gurion University Receive Approval for Second Year Grant to Continue the Collaboration Focused on Improving Crustacean Traits Utilizing Gene Editing Technology
Following a successful first year, Israel Innovation Authority (IIA) approved financing second year of collaboration
HAZEVA and REHOVOT, Israel, Oct. 8, 2024/PRNewswire/ -- Watershed AC ("Watershed", formerly Colors Farm Ltd.), a cutting-edge company in sustainable aquaculture and biote...
No comment yet